New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

From X

@BrokenMoats 1 click

Broken Moats on X

$suja dug in on a recent ipo that has collapsed, weirdly saw a bunch of people commenting on it and got curious. On the service it seems cheap, but EBITDA is not FCF. And I struggle to understand how the business scales the way the bulls and the sell side want you to believe it will. Cumulative fcf has been negative for years, and of course they cleaned the books for an ipo year, so numbers elevated td, but still nothing to get excited about and forward numbers already look disappointing right of the gate versus S1 guidance (a very bad look, and terrible way to establish trust with investors and sell side coverage) New mgmt background is uninspiring Debt load is quite high even post ipo, the recently lowered interest rate is nice for delta in income statement benefits next few quarters but still have a cash flow problem but this was a nice development. No idea what the slice business is or how it fits - it would be massively cash consuming if they actually try to compete in that space saturated with deep pocketed players like poppi and many other players with national advertising campaigns and distribution/shelf agreements with players like $KO and $PEP (slice is never going to get any meaningful mind awareness or share without massive marketing investment, and Suja does not have the capital or FCF to pull that off. The 90s nosteliga approach already worn off from the early 2025 launch as its not a relaunch of that heritage brand, it's just the ip wrapped as a prebiotic soda. ---it seems more like a story to dangle to get the ipo out that they can sell a huge TAM in their s1, which is a further strike against the board, the PE sponsor and mgmt (likely it just sits at the range its at and gets slowly unwound in a year or two to stop further cash bleed) PE sponsored and +60% owner -- can be your friend on locking float, but also your enemy when they need liquidity, the lock up period ends, or decide to move on. --- one of their other exits through IPO went a similar way, massively collapsed in value after the ipo, wallowed for a number of years and ultimately the PE firm bought out the remaining shares at pennies on the dollar to the IPO price (agrofresh) --Structure of ownership and tax agreements is highly unfriendly to passive long common equity shareholders (good for sponsor) Ultimately its an uninspired story, that is more expensive than it appears with fully diluted shares, a very difficult consumer space that relies on trends, shelf space staying in front of KO and PEP and BUD in addition to many many others on distribution and shelf space - a concentrated number of distribution points that gives power to their buyers (highly concentrated customer base on their sales (grocery channel) Stock probably bounces along the way especially in fronton or right after the coming lockup and the market loves to squeeze things one last time before their final resting space, and the tighter float here (assuming pe stays in) likely makes that more likely an outcome than not. So a swing trader after a brutal IPO? sure I would likely bet up before it's back in time out likely for good. But as an actual investment? let alone long term investment? I find that argument deeply flawed on both financial and fundamental basis

Investor Letters

All letters

Trading Post November 5, 2026

MercadoLibre’s logistics expansion cut margins by 60 basis points, while Mercado Pago grew credit 62% with 7% NPLs.

MELI $77B
Cassandra Unchained 2 clicks

Intel: The CPU Comeback, Discounted

Intel's Q3 2026 results were hit by memory costs and an Israel shutdown, but enterprise AI inference could lift CPU demand as server…

INTC $287B
Monte Independent Investment Research 2 clicks

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 8 clicks

eToro: Expanding Beyond Crypto

EToro trades at 2.89x EV/FCF with $304 million in trailing free cash flow, expanding from crypto into equities, commodities, currencies and…

ETOR $1.9B
Max Arnoldi 6 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 6 clicks

New Ideas From The Road

Aurelion Research increased healthcare exposure and sees opportunities in banking and defense, alongside research on Alcoa, Nike, ONON and…

AA $10BNKE $60B
Aurelion Research 5 clicks

Oracle: The Party Is Almost Over

Oracle’s CDS spreads exceed 320 basis points as debt approaches $135 billion and fiscal 2027 capex targets $95 billion, amid heavy reliance…

ORCL $363B
David Desjardins 1 click

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 79 of 282

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

360 firms

Sectors

Ordered by how often our editor reaches for them.